Hoe Pharma


Zuellig Pharma


Taisho Pharmaceutical
Concise Prescribing Info
Betamethasone dipropionate
Suppression of skin diseases in which inflammation is a prominent feature eg, eczema, atopic dermatitis, dermatitis herpetiformis, contact dermatitis, dermatitis venenata, seborrhoeic dermatitis, neurodermatitis, psoriasis & intertrigo.
Dosage/Direction for Use
Apply sparingly to the affected areas once daily or bd.
Hypersensitivity to betamethasone dipropionate, other corticosteroids, or any component in the base. Viral infections of the skin (eg, vaccinia, varicella & Herpes simplex), TB & acne rosacea.
Special Precautions
Discontinue use if irritation or sensitivity develops. Extensive surface area under occlussive dressing. Not suitable for ophth use. Pregnancy & lactation. Childn.
Adverse Reactions
Burning, itching, irritation, dryness folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, maceration of the skin, secondary infection, skin atrophy, striae & miliria.
ATC Classification
D07AC01 - betamethasone ; Belongs to the class of potent (group III) corticosteroids. Used in the treatment of dermatological diseases.
Additional Information
Exemptions granted for limited sale and supply without prescription (with effect from 31 March 2016):
As a topical preparation (as valerate or dipropionate salt) as a single agent not exceeding 0.1%
Indication: Symptomatic relief of inflammatory skin or scalp disorders such as dermatitis and eczema
Maximum daily dose: Apply to affected areas twice daily
Maximum supply: 15 g for cream/ointment/gel; 30 ml for topical solution
Minimum age: 18 years
Beprogel topical soln 0.64 mg/mL
30 mL x 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in